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In the preceding article, Ewert et al. [1] describe a
technique in which they implant in piglets stents that
have been split longitudinally. The sides of the stent were
reattached using absorbable sutures that, when absorbed,
allow for further expansion of the stents. These modified
stents were placed in normal inferior venae cavae, de-
scending aortae, or pulmonary arteries through a 5 Fr
sheath. The animals were recatheterized 14–23 weeks
later. In no instance was a pressure gradient recorded
across the stented vessel segment. In 10 of 20 stents,
there was angiographic appearance of narrowing of no
more than 10% of the vessel diameter. These stents were
redilated successfully, although the definition of “suc-
cessful” is not given. The authors conclude that this “may
be a promising new device for the permanent treatment
of stenotic vessels in infancy and childhood.”
The primary advantage of this technique seems to be
that the stents can implanted through small (5 Fr)
sheaths. However, one must interpret this report with
caution. As the authors themselves point out, these stents
were implanted in native nonstenotic vessels. Whether
similar success is achievable in diseased stenotic vessels
is not clear. Additionally, the fact that the radial strength
of this split stent will be disturbed could be of major
concern. Redilating, especially using high-pressure bal-
loons, is likely to deliver outward forces to the stenotic
vessel in a nonuniform manner. This nonhomogeneity of
force coupled with the increased elastic filaments, which
were stretched and widely separated as demonstrated in
the present report, raises serious questions about the use
of this technique in small infants with diseased vessels.
This concern would also be true for a stent with a single
longitudinal split, as described by Ing et al. [2]. Finally,
the fact that the two halves of the stents described in the
present report had separated with growth of the vessel
raises the question as to how much they are responsible
for the lack of stenosis in the older animals.
Another stent with a novel design described by Forbes
et al. [3] has many of the characteristics desirable in a
stent that can be redilated to a larger size in growing
children. This stent, which is not split, requires a 6 Fr
sheath for implantation, but it is flexible enough to be
implanted in the pulmonary arteries and can be dilated up
to 20 mm. Because of the design of the stent, interposing
omega hinges between cells, it maintains uniform radial
strength with little shortening on subsequent dilation,
unlike a similar stent without the newer design [4].
The issue of implanting stents in infants and small
children has been problematic because of the inability to
dilate the stents to an adequate size as the child grows.
Innovations, such as the one described in this report, have
begun to address this issue. As with many other devel-
opments in the catheterization laboratory, it is only a
matter of time before this issue is resolved. Whether the
right technique will include use of a split stent or some
other design remains to be seen.
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